AttendMe Owl Logo
AttendMe
Sign In
All Pathways
Internal MedicineManagement

Hypothyroidism Management (ATA Guidelines)

Hypothyroidism Management (ATA Guidelines): Suspected Hypothyroidism → Initial Workup → TSH Result → Overt Hypothyroidism → Levothyroxine Dosing.

Pathway Overview

13 steps

Algorithm Steps

13 total

  1. 01Start

    Suspected Hypothyroidism

    Fatigue, cold intolerance, constipation, weight gain

  2. 02Action

    Initial Workup

    TSH is primary screening test

    • TSH (most sensitive)
    • Free T4 if TSH abnormal
    • TPO antibodies if etiology unclear
  3. 03Decision

    TSH Result

    Interpret with free T4

    • High TSH, low FT4 = overt hypothyroidism
    • High TSH, normal FT4 = subclinical
    • Normal TSH = euthyroid
  4. 04Action

    Overt Hypothyroidism

    TSH elevated, FT4 low

    • Treat with levothyroxine
    • Initial dose: 1.6 mcg/kg/day (full replacement)
    • Start lower in elderly/CAD: 25-50 mcg/day
    • Take on empty stomach, AM
  5. 05Action

    Levothyroxine Dosing

    Age and cardiac status matter

    • Young healthy: 1.6 mcg/kg/day
    • Elderly or CAD: start 12.5-25 mcg/day
    • Increase by 12.5-25 mcg q4-6 weeks
    • Brand consistency recommended
  6. 06Action

    Monitoring

    TSH follow-up

    • Recheck TSH 6-8 weeks after dose change
    • Goal TSH: 0.5-2.5 mIU/L for most
    • Higher TSH ok in elderly (up to 6-8)
    • Once stable: annual TSH
  7. 07Action

    TSH Still Elevated

    Increase dose or address adherence

    • Increase by 12.5-25 mcg
    • Check adherence (timing, empty stomach)
    • Drug interactions: calcium, iron, PPI
    • Malabsorption (celiac, GI surgery)
  8. Path rejoins step 06Shared downstream outcome
  9. 08Outcome

    TSH at Goal

    Continue current dose

    • Annual TSH monitoring
    • Dose may need adjustment:
    • - Weight changes
    • - Pregnancy
    • - Age >65 (may need less)
  10. 09Warning

    TSH Suppressed (<0.5)

    Over-replacement

    • Risk: AFib, osteoporosis
    • Reduce dose by 12.5-25 mcg
    • Recheck in 6-8 weeks
    • Exception: thyroid cancer suppression
  11. 10Decision

    Subclinical Hypothyroidism

    TSH elevated, FT4 normal

    • TSH 4.5-10: repeat in 6-12 weeks
    • TSH >10: consider treatment
    • Treat if: symptomatic, TPO+, pregnancy desired
  12. 11Action

    Treat Subclinical

    If criteria met

    • Start low: 25-50 mcg/day
    • Lower threshold to treat if:
    • - Symptoms present
    • - TPO antibodies positive
    • - TSH >10
    • - Pregnancy or planning
  13. Path rejoins step 06Shared downstream outcome
  14. 12Action

    Observe Subclinical

    If mild and asymptomatic

    • Recheck TSH in 6-12 months
    • May normalize spontaneously
    • Treat if worsens or develops symptoms
  15. 13Outcome

    Euthyroid (Normal TSH)

    No thyroid disease

    • Consider non-thyroid causes of symptoms
    • No further thyroid workup needed

Guideline Source

Guidelines for the Treatment of Hypothyroidism (ATA/AACE)

DOI: 10.1089/thy.2014.0028View Guideline

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not cover subclinical hypothyroidism in detail
  • Pregnancy hypothyroidism needs OB input
  • Central hypothyroidism requires specialist evaluation
  • Does not address myxedema coma (emergency)
  • Drug dosing requires individualization

Applicable Regions

USEU

EU: ETA guidelines similar

US: Based on ATA guidelines

Version 1Next review: 2027-01-11

Related Internal Medicine Pathways

Acute Hyperkalemia Management - Hospitalist

Emergency

Acute Hypokalemia Management - Hospitalist

Emergency

Acute Hyponatremia Management - Hospitalist

Emergency

Acute Kidney Injury - Hospitalist Approach (KDIGO)

Emergency

Next steps

Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.

Calculator

Charlson Comorbidity Index

Comorbidity burden and 10-year mortality prediction

Open page

Compare

AttendMe.ai vs ChatGPT

See how this pathway workflow compares against ChatGPT.

Open page

Commercial

Start free

Run the pathway in a live AttendMe account with citations and tracked usage.

Start free

Related Resources

All Clinical PathwaysClinical CalculatorsAI Chat with Auto-Detection

Frequently Asked Questions

What is the Hypothyroidism Management (ATA Guidelines)?

The Hypothyroidism Management (ATA Guidelines) is a management clinical algorithm for Internal Medicine. It provides a structured decision tree to guide clinical decision-making, based on Guidelines for the Treatment of Hypothyroidism (ATA/AACE).

What guideline is the Hypothyroidism Management (ATA Guidelines) based on?

This algorithm is based on Guidelines for the Treatment of Hypothyroidism (ATA/AACE) (DOI: 10.1089/thy.2014.0028).

What are the limitations of the Hypothyroidism Management (ATA Guidelines)?

Known limitations include: Does not cover subclinical hypothyroidism in detail; Pregnancy hypothyroidism needs OB input; Central hypothyroidism requires specialist evaluation; Does not address myxedema coma (emergency); Drug dosing requires individualization. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hypothyroidism Management (ATA Guidelines) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free